Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

Email
Yvonne Duglas-Tabor

Yvonne Duglas-Tabor

Program Associate Director
Division of Cancer Biology (DCB)
Cancer Immunology, Hematology, and Etiology Branch
240-276-6234
|
duglasy@mail.nih.gov

Yvonne Duglas-Tabor manages R01, R15, and R03 grants related to cancer immunology and cancer disparities, as well as has expertise in the role that the immune system plays in leukemia/lymphoma pathogenesis. 

She says, “It’s imperative that the NCI extramural and intramural workforce in research represent the people that we serve” and is committed to health disparities research.

 

Background

Prior to coming to the NCI, Ms. Duglas-Tabor was a Senior Research Technician in the  Laboratory of Molecular Ocular Diseases at the National Eye Institute (NEI), where she was the expert in 2D electrophoresis and TOF mass spectroscopy. 

 

Education

B.A., Biology, Immaculata College
B.S., Computer Management Information Systems, University of Maryland
 

  • Updated:
Email